Stainsby, C. M., Perger, T. M., Vannappagari, V., Mounzer, K. C., Hsu, R. K., Henegar, C. E., . . . Shaefer, M. S. (2018). Abacavir Hypersensitivity Reaction Reporting Rates During a Decade of HLA‐B*5701 Screening as a Risk‐Mitigation Measure. Pharmacotherapy.

Stainsby, Chris M., et al. "Abacavir Hypersensitivity Reaction Reporting Rates During a Decade of HLA‐B*5701 Screening As a Risk‐Mitigation Measure." Pharmacotherapy 2018.

Stainsby, Chris M., et al. "Abacavir Hypersensitivity Reaction Reporting Rates During a Decade of HLA‐B*5701 Screening As a Risk‐Mitigation Measure." Pharmacotherapy 2018.